July 10, 2018
Myocant Sciences complets screening patients for heavy menstrual bleeding study
Myovant Sciences has completed screening patients for its LIBERTY 1 study, the first of two Phase 3 replicate studies evaluating…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
July 2, 2018
Alvogen, Prestige BioPharma in Hervelous selling deal for Central and Eastern Europe
Alvogen and Prestige BioPharma have entered into a deal for the exclusive partnership and supply for the commercialization of Prestige…
July 2, 2018
AstraZeneca’s lung cancer drug approved in Japan
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the Japanese Ministry of Health, Labour and…
June 29, 2018
CHMP recommends approval of Sanofi’s Cablivi
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Cablivi (caplacizumab) in Europe…
June 29, 2018
Novartis aims at spinoff of Alcon eye care devices business
Novartis on Friday said it intends to spinoff Alcon, its eye care division, into a separately-traded standalone company, which would…
June 28, 2018
Sanofi and Advent in negotiations for €1.9 billion acquisition of Zentiva
Sanofi and Advent International have finished negotiations for the acquisition of Zentiva, Sanofi’s European generics business, by Advent and the…
June 28, 2018
Better prevention can curbe significant disruption to daily life and work caused by migraine
Novartis and the European Migraine and Headache Alliance (EMHA) Wednesday presented initial findings from the largest global migraine patient study…
June 27, 2018
Lynparza significantly delays disease progression in Phase III 1st-line SOLO-1 trial for ovarian cancer
AstraZeneca and Merck’s Phase III SOLO-1 trial of Lynparza (olaparib) tablets, for women with BRCA-mutated (BRCAm) advanced ovarian cancer treated…
June 27, 2018
Symcel appoints two new board members to bolster R&D business growth and expansion into the clinical diagnostics market
Symcel said Wednesday it has appointed two new board members; Erik Walldén and Stefan Löfås, who are expected to play a…
June 27, 2018
Servier, Galapagos kick off therapeutic candidate phase 2 trial for knee osteoarthritis patients
Servier and Galapagos NV have started a global Phase 2 trial with S201086/GLPG1972 in knee osteoarthritis patients, titled Roccella, in…